UBS AM’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
173,598
+76,175
| +78% | +$620K | ﹤0.01% | 2291 |
|
|
2025
Q1 | $765K | Buy |
97,423
+35,409
| +57% | +$278K | ﹤0.01% | 2407 |
|
|
2024
Q4 | $923K | Sell |
62,014
-7,872
| -11% | -$117K | ﹤0.01% | 2399 |
|
|
2024
Q3 | $1.07M | Sell |
69,886
-26,966
| -28% | -$412K | ﹤0.01% | 2363 |
|
|
2024
Q2 | $1.48M | Sell |
96,852
-281,211
| -74% | -$4.28M | ﹤0.01% | 2158 |
|
|
2024
Q1 | $7.14M | Sell |
378,063
-20,603
| -5% | -$389K | ﹤0.01% | 1118 |
|
|
2023
Q4 | $7.61M | Sell |
398,666
-7,381
| -2% | -$141K | ﹤0.01% | 1091 |
|
|
2023
Q3 | $7.29M | Sell |
406,047
-5,253
| -1% | -$94.3K | ﹤0.01% | 1063 |
|
|
2023
Q2 | $7.5M | Hold |
411,300
| – | – | ﹤0.01% | 1071 |
|
|
2023
Q1 | $7.5M | Buy |
411,300
+9,531
| +2% | +$174K | ﹤0.01% | 1071 |
|
|
2022
Q4 | $8.31M | Sell |
401,769
-44,965
| -10% | -$930K | ﹤0.01% | 1008 |
|
|
2022
Q3 | $11.7M | Sell |
446,734
-3,821
| -0.8% | -$100K | 0.01% | 906 |
|
|
2022
Q2 | $11.4M | Buy |
450,555
+136,717
| +44% | +$3.46M | 0.01% | 910 |
|
|
2022
Q1 | $9.9M | Buy |
313,838
+72,627
| +30% | +$2.29M | ﹤0.01% | 1070 |
|
|
2021
Q4 | $9.76M | Buy |
241,211
+199,634
| +480% | +$8.08M | ﹤0.01% | 1134 |
|
|
2021
Q3 | $1.45M | Buy |
41,577
+4,557
| +12% | +$159K | ﹤0.01% | 1974 |
|
|
2021
Q2 | $1.02M | Buy |
37,020
+3,634
| +11% | +$99.8K | ﹤0.01% | 2209 |
|
|
2021
Q1 | $937K | Sell |
33,386
-4,329
| -11% | -$122K | ﹤0.01% | 2124 |
|
|
2020
Q4 | $979K | Buy |
37,715
+14,915
| +65% | +$387K | ﹤0.01% | 2006 |
|
|
2020
Q3 | $391K | Sell |
22,800
-8,015
| -26% | -$137K | ﹤0.01% | 2234 |
|
|
2020
Q2 | $762K | Buy |
+30,815
| New | +$762K | ﹤0.01% | 1920 |
|
|
2018
Q2 | – | Sell |
-41,652
| Closed | -$643K | – | 2801 |
|
|
2018
Q1 | $643K | Buy |
+41,652
| New | +$643K | ﹤0.01% | 1929 |
|